The Impact of Serum Vitamin D Concentration on Median Nerve Conduction
Abstract
Objectives: To perform nerve conduction studies (NCS)
and to evaluate distal latency, amplitude and conduction velocity values of the
median nerve in relation to serum vitamin D levels in patients with neuropathic
symptoms compared to controls.
Patients and Methods: Patients with
neuropathic symptoms of numbness, tingling and burning sensation were included
in the study. Serum 1,25(OH) D3 levels were measured and patients were
stratified by vitamin D status into three subgroups. Electrophysiological
assessments of the median nerve were performed as recommended by the American
Society of Electrodiagnostic Medicine. SPSS for Windows, version 24 was
used for statistical analyses. Median nerve conduction values were compared
between patient and control groups in relation to vitamin D concentration.
Results: The study enrolled 39 patients including
24 (61.5%) males and 15 (38.5%) females and 39 control subjects including 22
(56.4%) males 17 (43.6%) females. Patient and control groups had a mean age of 45
years. Average vitamin D concentration was 8.5 ng/ml in the patient group and
8.8 ng/ml in the control group. There was no statistically significant
difference between two groups with respect to age and average vitamin D
concentration (p=0.552). Greater distal latency values and a statistically
significant association between median nerve distal latency and vitamin D
deficiency were found in the vitamin D-deficient subgroup (p=0.024).
Conclusion: Given the neuroprotective action of
vitamin D and the involvement of vitamin D deficiency in several neurological
diseases as well as evidence that it might be an independent risk factor and a
potential biomarker for neuropathy, we believe that patients presenting with
mononeuropathy or polyneuropathy to a healthcare facility should be screened
for vitamin D deficiency.
Keywords
Kaynakça
- 1. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing “D“ecline? Mol. Aspects Med. 2008;29:415–22.
- 2. Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochem Biophys Res. Commun. 2015;456:631–6.
- 3. Prakash S, Mehta NC, Dabhi AS, Lakhani O, Khilari M, Shah ND. The prevalence of headache may be related with the latitude: A possible role of Vitamin D insufficiency? J Headache Pain. 2010;11:301–7.
- 4. Andıran N, Çelik N, Akça H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol. 2012;4:25–9.
- 5. Katz JN, Simmons BP. Carpal tunnel syndrome. N Eng J Med. 2002; 346:1807-12.
- 6. D’Arcy CA, McGee S. The rational clinical examination. Does this patient have carpal tunnel syndrome? JAMA 2000; 283:3110-7.
- 7. Uchiyama S, Itsubo T, Nakamura K, Kato H, Yasutomi T, Momose T. Current concepts of carpal tunnel syndrome. Pathophysiology, treatment and evaluation. J Orthop Sci. 2010;15:1-13.
- 8. Karpitskaya Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus, and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg. 2002;48:269–73.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Gökhan Özer
*
Türkiye
Yayımlanma Tarihi
13 Haziran 2018
Gönderilme Tarihi
10 Mart 2018
Kabul Tarihi
10 Nisan 2018
Yayımlandığı Sayı
Yıl 2018 Cilt: 9 Sayı: 2